159 related articles for article (PubMed ID: 32459546)
21. Clinical course of juvenile myelomonocytic leukemia in the blast crisis phase treated by acute myeloid leukemia-oriented chemotherapy and allogeneic hematopoietic stem cell transplantation.
Ueda S; Sakata N; Muramatsu H; Sakaguchi H; Wang X; Xu Y; Kojima S; Yamaguchi T; Higa T; Takemura T
Int J Hematol; 2014 Nov; 100(5):502-6. PubMed ID: 25047104
[TBL] [Abstract][Full Text] [Related]
22. Allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukemia with intestinal Behçet's disease: A case report.
Liu C; Fu C; Guo X; Rong L; Li J; Fang Y
Int J Rheum Dis; 2024 Jan; 27(1):e14882. PubMed ID: 37771000
[TBL] [Abstract][Full Text] [Related]
23. Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.
Locatelli F; Zecca M; Messina C; Rondelli R; Lanino E; Sacchi N; Uderzo C; Fagioli F; Conter V; Bonetti F; Favre C; Porta F; Giorgiani G; Pession A
Leukemia; 2002 Nov; 16(11):2228-37. PubMed ID: 12399966
[TBL] [Abstract][Full Text] [Related]
24. Control of thrombotic thrombocytopenic purpura by sirolimus in a child with juvenile myelomonocytic leukemia and somatic N-RAS mutation.
Maschan M; Bobrynina V; Khachatryan L; Kalinina I; Solopova G; Avdonin P; Nasedkina T; Novichkova G; Maschan A
Pediatr Blood Cancer; 2014 Oct; 61(10):1871-3. PubMed ID: 24590757
[TBL] [Abstract][Full Text] [Related]
25. Treatment of juvenile chronic myeloid leukemia with sequential subcutaneous cytarabine and oral mercaptopurine.
Lilleyman JS; Harrison JF; Black JA
Blood; 1977 Apr; 49(4):559-62. PubMed ID: 265178
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics of 15 children with juvenile myelomonocytic leukaemia who developed blast crisis: MDS Committee of Japanese Society of Paediatric Haematology/Oncology.
Honda Y; Tsuchida M; Zaike Y; Masunaga A; Yoshimi A; Kojima S; Ito M; Kikuchi A; Nakahata T; Manabe A
Br J Haematol; 2014 Jun; 165(5):682-7. PubMed ID: 24588411
[TBL] [Abstract][Full Text] [Related]
28. Adults with germline CBL mutation complicated with juvenile myelomonocytic leukemia at infancy.
Muraoka M; Okuma C; Kanamitsu K; Ishida H; Kanazawa Y; Washio K; Seki M; Kato M; Takita J; Sato Y; Ogawa S; Tsukahara H; Oda M; Shimada A
J Hum Genet; 2016 Jun; 61(6):523-6. PubMed ID: 26911351
[TBL] [Abstract][Full Text] [Related]
29. [Role of allogeneic transplantation of bone marrow in juvenile chronic myelomonocytic leukemia].
Lutz P; Folléa G; Albert A; Falkenrodt A; Jung JJ; Masson E; Lévy JM
Presse Med; 1988 Nov; 17(40):2113-6. PubMed ID: 2974139
[TBL] [Abstract][Full Text] [Related]
30. Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
De Astis E; Clavio M; Raiola AM; Ghiso A; Guolo F; Minetto P; Galaverna F; Miglino M; Di Grazia C; Ballerini F; Marani C; Pastori G; Mitscheunig L; Cruciani F; Lovera D; Varaldo R; Ghiggi C; Lemoli RM; Bacigalupo A; Gobbi M
Ann Hematol; 2014 Dec; 93(12):2011-8. PubMed ID: 24989345
[TBL] [Abstract][Full Text] [Related]
31. Differentiating juvenile myelomonocytic leukemia from chronic myeloid leukemia in childhood.
Chang YH; Jou ST; Lin DT; Lu MY; Lin KH
J Pediatr Hematol Oncol; 2004 Apr; 26(4):236-42. PubMed ID: 15087951
[TBL] [Abstract][Full Text] [Related]
32. Juvenile Myelomonocytic Leukemia in Turkey: A Retrospective Analysis of Sixty-five Patients.
Tüfekçi Ö; Koçak Ü; Kaya Z; Yenicesu İ; Albayrak C; Albayrak D; Yılmaz Bengoa Ş; Patıroğlu T; Karakükçü M; Ünal E; Ünal İnce E; İleri T; Ertem M; Celkan T; Özdemir GN; Sarper N; Kaçar D; Yaralı N; Özbek NY; Küpesiz A; Karapınar T; Vergin C; Çalışkan Ü; Tokgöz H; Sezgin Evim M; Baytan B; Güneş AM; Yılmaz Karapınar D; Karaman S; Uygun V; Karasu G; Yeşilipek MA; Koç A; Erduran E; Atabay B; Öniz H; Ören H
Turk J Haematol; 2018 Mar; 35(1):27-34. PubMed ID: 28179213
[TBL] [Abstract][Full Text] [Related]
33. Short-term efficacy of decitabine-based therapy in JMML: a retrospective study from a single center in China.
Cai Y; Zhang J; Yi M; Zhang W; Liu X; Zhang X; Wan Y; Chang L; Zhang L; Chen X; Guo Y; Zou Y; Chen Y; Li J; Zhang Y; Yang W; Zhu X
Int J Hematol; 2023 Jan; 117(1):121-127. PubMed ID: 36182987
[TBL] [Abstract][Full Text] [Related]
34. DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia.
Flotho C; Sommer S; Lübbert M
Semin Cancer Biol; 2018 Aug; 51():68-79. PubMed ID: 29129488
[TBL] [Abstract][Full Text] [Related]
35. Graft versus leukemia effect against juvenile myelomonocytic leukemia after unrelated cord blood transplantation.
Tanoshima R; Goto H; Yanagimachi M; Kajiwara R; Kuroki F; Yokota S
Pediatr Blood Cancer; 2008 Mar; 50(3):665-7. PubMed ID: 17437289
[TBL] [Abstract][Full Text] [Related]
36. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
37. Combination of DNA-hypomethylating agent and hematopoietic stem cell transplantation in treatment of juvenile myelomonocytic leukemia: A case report.
Ai Y; Lu X; Zhu T; Zhu Y; Liu H; Sun S
Medicine (Baltimore); 2020 Dec; 99(50):e23606. PubMed ID: 33327329
[TBL] [Abstract][Full Text] [Related]
38. Successful hematopoietic stem cell transplantation from an HLA-mismatched parent for engraftment failure after unrelated cord blood transplantation in patients with juvenile myelomonocytic leukemia: Report of two cases.
Akahane K; Watanabe A; Furuichi Y; Somazu S; Oshiro H; Goi K; Sakashita K; Muramatsu H; Hama A; Takahashi Y; Koike K; Kojima S; Sugita K; Inukai T
Pediatr Transplant; 2019 May; 23(3):e13378. PubMed ID: 30786117
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and treatment of juvenile myelomonocytic leukemia.
Sakashita K; Matsuda K; Koike K
Pediatr Int; 2016 Aug; 58(8):681-90. PubMed ID: 27322988
[TBL] [Abstract][Full Text] [Related]
40. Association of fludarabin, cytarabine, and fractioned gemtuzumab followed by hematopoietic stem cell transplantation for first-line refractory acute myeloid leukemia in children: A single-center experience.
Penel-Page M; Plesa A; Girard S; Marceau-Renaut A; Renard C; Bertrand Y
Pediatr Blood Cancer; 2020 Jun; 67(6):e28305. PubMed ID: 32307866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]